Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone)
Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: Today I’m joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today. Dr John Kim: Oh, you’re welcome. It’s my pleasure and honour to share this wonderful […]
Judy – US: Sympathetic Autonomic Nervous System Disorder, PTSD, 22 Jan 2020 (LDN, low dose naltrexone)
Judy – US: Sympathetic Autonomic Nervous System Disorder, PTSD (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Linda Elsegood: I’d like to introduce Judy from the U.S. She was diagnosed with sympathetic autonomic nervous system disorder due to chronic PTSD and trauma. Thanks for joining us today, Judy. Judy: [00:01:13] Thank you. Linda […]
Dr Richard Nahas, LDN Radio Show 2016 (LDN, low dose naltrexone)
Dr Richard Nahas, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Richard Nahas shares their Low Dose Naltrexone (LDN) Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health. Dr Nahas practices in Ottawa, Canada at the Seekers Centre. He […]
Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone)
Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health.Dr […]
Benefits Of Taking Low Dose Naltrexone (News)
Benefits Of Taking Low Dose Naltrexone KHTS HometownStation 23 August 2021 https://www.hometownstation.com/news-articles/benefits-of-taking-low-dose-naltrexone-387863 Low doses of Naltrexone has proven multiple advantages and benefits, some of which are discussed in this article. Low Dose Naltrexone is prescribed at doses of between 0.5 to 4.5mg. At this low dose, Naltrexone blocks the opioid receptors for a few hours. […]
Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone)
Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr. Kat Toups is an MD from California in the US, a functional medicine doctor and a psychiatrist. After graduating, being a psychiatrist I ending up working in a research centre, found trials and studies on […]
Dr Jordan Atkinson, LDN Radio Show 12 May 2017 (LDN, low dose naltrexone)
Dr Jordan Atkinson, LDN Radio Show 12 May 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Jordan Atkinson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Jordan Atkinson, based in Vancouver, has utilised LDN for a variety of autoimmune conditions and cancer with […]
Pharmacist Dr Ike – US, LDN Radio Show 09 June 2017 (LDN, low dose naltrexone)
Pharmacist Dr Ike – US, LDN Radio Show 09 June 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Pharmacist Dr Ike is the CEO and founder of Enovex Total Wellness Pharmacy. He is a compassionate health care practitioner, cares about the health of every patient and tries hard to have all the […]
Complex Regional Pain Syndrome: A Comprehensive Review (Abstract)
Complex Regional Pain Syndrome: A Comprehensive Review Pain Ther 24 June 2021 https://pubmed.ncbi.nlm.nih.gov/34165690/ Complex regional pain syndrome (CRPS) is a chronic pain condition often involving hyperalgesia and allodynia of the extremities. CRPS is divided into CRPS-I and CRPS-II. Type I occurs when there is no confirmed nerve injury. Type II is when there is known […]
Morphine reduced perceived anger from neutral and implicit emotional expressions (Abstract)
Morphine reduced perceived anger from neutral and implicit emotional expressions Psychoneuroendocrinology May 2018 https://pubmed.ncbi.nlm.nih.gov/29550675/ The μ-opioid system modulates responses to pain and psychosocial stress and mediates non-social and social reward. In humans, the μ-opioid agonist morphine can increase overt attention to the eye-region and visual exploration of faces with neutral expressions. However, little is known […]